Top House Dem Buys Stock in Pharma Companies and Defense Contractors
House Budget Chair John Yarmuth is a frequent stock trader who recently purchased shares in companies that are lobbying against the Democrats' budget plan.
Page 2
House Budget Chair John Yarmuth is a frequent stock trader who recently purchased shares in companies that are lobbying against the Democrats' budget plan.
Leaders of a centrist advocacy group with funding from the pharmaceutical industry founded outlet The Well News and have editorial input on its promoted posts.
The largest drugmakers spent $56 billion more on stock buybacks and dividends than on research and development from 2016 to 2020, according to a new House committee report.
The plan, initiated by the Trump administration in January, would gut a key government power for making sure taxpayer-funded pharmaceuticals are available to the public at reasonable prices.
An anti-government waste group is helping its Big Pharma funder oppose a discount drug program that doesn’t cost the government a penny.
Center Forward, a "dark money" group with major funding from Big Pharma, is running a Facebook ad campaign touting the pharmaceutical industry as its super PAC spends millions to re-elect Blue Dog Democrats.